MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$154.04
−2.55%0
Insider buys (3m)
10
Insider sells (3m)
-$49.2M
Net value (3m)
+160.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Hoge Stephen · officer: President | Sale | 40,294 | $144 |
| Sep 16, 2026 | Hoge Stephen · officer: President | M-Exempt | 76,453 | $12 |
| Sep 16, 2026 | Hoge Stephen · officer: President | Sale | 40,281 | $146 |
| Sep 16, 2026 | Hoge Stephen · officer: President | M-Exempt | 76,452 | $12 |
| Sep 14, 2026 | Mock James M · officer: Chief Financial Officer | M-Exempt | 19,836 | $31 |
| Sep 14, 2026 | Mock James M · officer: Chief Financial Officer | Sale | 15,000 | $134 |
| Sep 14, 2026 | Mock James M · officer: Chief Financial Officer | Sale | 19,836 | $134 |
| Sep 8, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | F-InKind | 5,704 | $149 |
| Sep 8, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | M-Exempt | 11,797 | $0.00 |
| Sep 8, 2026 | Mock James M · officer: Chief Financial Officer | M-Exempt | 11,797 | $0.00 |
| Sep 8, 2026 | Mock James M · officer: Chief Financial Officer | F-InKind | 5,704 | $149 |
| Sep 3, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | Sale | 3,471 | $140 |
| Sep 3, 2026 | Mock James M · officer: Chief Financial Officer | F-InKind | 1,197 | $140 |
| Sep 3, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | M-Exempt | 3,471 | $31 |
| Sep 3, 2026 | Hoge Stephen · officer: President | M-Exempt | 9,283 | $0.00 |
| Sep 3, 2026 | Hoge Stephen · officer: President | F-InKind | 4,489 | $140 |
| Sep 3, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | F-InKind | 1,048 | $140 |
| Sep 3, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | M-Exempt | 2,166 | $0.00 |
| Sep 3, 2026 | Mock James M · officer: Chief Financial Officer | M-Exempt | 2,475 | $0.00 |
| Aug 31, 2026 | Mock James M · officer: Chief Financial Officer | F-InKind | 160 | $143 |
| Aug 31, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | M-Exempt | 329 | $0.00 |
| Aug 31, 2026 | Mock James M · officer: Chief Financial Officer | M-Exempt | 774 | $0.00 |
| Aug 31, 2026 | Hoge Stephen · officer: President | M-Exempt | 611 | $0.00 |
| Aug 31, 2026 | Hoge Stephen · officer: President | F-InKind | 695 | $150 |
| Aug 31, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | F-InKind | 160 | $143 |
| Aug 31, 2026 | Mock James M · officer: Chief Financial Officer | M-Exempt | 329 | $0.00 |
| Aug 31, 2026 | Hoge Stephen · officer: President | F-InKind | 296 | $143 |
| Aug 31, 2026 | Klinger Shannon Thyme · officer: Chief Legal Officer | F-InKind | 375 | $150 |
| Aug 31, 2026 | Mock James M · officer: Chief Financial Officer | F-InKind | 375 | $150 |
| Aug 31, 2026 | Hoge Stephen · officer: President | M-Exempt | 1,437 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 306Increased 484Reduced 473Sold out 87
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 51,859,891 | Aug 13, 2026 |
| FMR LLC | Increased | 45,672,024 | May 15, 2026 |
| BlackRock, Inc. | Increased | 30,599,409 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 29,635,876 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 23,208,792 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 22,872,458 | May 15, 2026 |
| Capital World Investors | Increased | 22,276,996 | Aug 12, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 19,985,876 | May 8, 2026 |
| CAPITAL WORLD INVESTORS | Increased | 18,697,694 | May 13, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 18,206,778 | Aug 6, 2026 |
| STATE STREET CORP | Increased | 15,726,193 | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 15,616,367 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 15,581,313 | Aug 13, 2026 |
| STATE STREET CORP | Reduced | 14,861,409 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 12,575,740 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 16, 2026